Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
238.9 CHF | -0.13% | +0.08% | -9.33% |
07:18am | Chugai Pharmaceutical's Parent Roche Logs Lower Q1 Sales; Stock Falls 5% | MT |
Apr. 24 | ROCHE HOLDINGS AG : DZ Bank reiterates its Buy rating | ZD |
Sales 2024 * | 59.57B 65.21B | Sales 2025 * | 63.62B 69.65B | Capitalization | 179B 196B |
---|---|---|---|---|---|
Net income 2024 * | 13.27B 14.53B | Net income 2025 * | 14.64B 16.03B | EV / Sales 2024 * | 3.24 x |
Net Debt 2024 * | 13.95B 15.27B | Net Debt 2025 * | 7.84B 8.58B | EV / Sales 2025 * | 2.94 x |
P/E ratio 2024 * |
13
x | P/E ratio 2025 * |
11.9
x | Employees | 103,605 |
Yield 2024 * |
4.35% | Yield 2025 * |
4.51% | Free-Float | 88.91% |
Latest transcript on Roche Holding AG
1 day | -0.13% | ||
1 week | +0.08% | ||
Current month | -2.47% | ||
1 month | -0.59% | ||
3 months | -8.28% | ||
6 months | -6.47% | ||
Current year | -9.33% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 02-12-31 | |
Severin Schwan
CHM | Chairman | 57 | 07-12-31 |
Alan Hippe
DFI | Director of Finance/CFO | 57 | 11-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bernard Poussot
BRD | Director/Board Member | 72 | 15-03-02 |
Director/Board Member | 59 | - | |
Director/Board Member | 65 | 95-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.06% | 2 M€ | -.--% | - | |
2.06% | 2 M€ | +9.19% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 239 | -0.08% | 6 151 |
24-04-24 | 239.2 | -4.40% | 32,173 |
24-04-23 | 250.2 | +2.46% | 49,199 |
24-04-22 | 244.2 | +2.61% | 41,027 |
24-04-19 | 238 | +0.51% | 21,595 |
Delayed Quote Swiss Exchange, April 25, 2024 at 03:02 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.61% | 660B | |
+25.03% | 562B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+13.06% | 219B | |
+6.63% | 199B | |
-8.75% | 149B | |
-5.21% | 146B |
- Stock Market
- Equities
- ROG Stock
- RO Stock